Key Highlights

  • Senti Biosciences Subsidiary Senti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24.
  • The financing secures immediate funding for the company.
  • The transaction introduces potential share dilution.
  • The note establishes formal Debt obligations previously indicated in May 1, 2026 regulatory filings.

Senti Biosciences, Inc. (NASDAQ: SNTI) subsidiary Senti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24, securing immediate funding.

What Happened

The transaction introduces potential share dilution and establishes formal debt obligations, as previously indicated in the company's May 1, 2026 regulatory filings.

Market Reaction

The disclosed information does not include stock price or trading data for Senti Biosciences following the convertible note issuance.

Outlook

The disclosed information does not include specific forward guidance beyond the completed convertible note issuance; investors are likely to watch for how the new debt obligations and potential dilution affect the company's Capital Structure going forward.